BIO-TT Vaccine

DESCRIPTION
BIO-TT is a white homogeneous colloidal suspension in glass vial, contains purified tetanus toxoid, which is adsorbed onto aluminum phosphate.

COMPOSITION

Each dose (0.5 mL) contains :

Active Ingredient :

  • Purified tetanus toxoid     10 Lf.

Excipients :

  • Aluminum phosphate     1.5   mg
  • Thimerosal                         0.05 mg

INDICATION
Active immunization against tetanus and neonatorum tetanus by immunizing child bearing age woman.

MECHANISM OF ACTION
Stimulates the body to produce antibody against tetanus.

POSOLOGY

  • BIO-TT immunization for the prevention of tetanus/ neonatorum tetanus consists of two primary doses of 0.5 mL given intramuscularly at least four weeks apart followed by the third dose at least 6 months later.
  • BIO-TT vaccine may be given at the same time as BCG, Measles, Rubella, Mumps, Polio (OPV or IPV), Hepatitis B, Haemophilus influenzae type b, and Yellow Fever vaccines and vitamin A supplementation.

SIDE EFFECTS Rare and mild. Some temporary tenderness and redness at the site of the injection and occasional fever. It is safe to be given during pregnancy.

CONTRAINDICATION

  • A severe reaction to previous dose of tetanus immunization
  • Hypersensitive  to  one  of  elements  in vaccine
  • Should  not  be  given  to  those  having fever or acute infection. Can be administered to those having minor afebrile illness such as mild infection on the upper respiration tracks.

IMMUNE DEFICIENCY

Persons infected with human immunodeficiency virus (HIV), both asymptomatic and symptomatic, should be immunized with BIO-TT vaccine according to standard schedules.

DRUG INTERACTION
Not Reported

STORAGE

  • BIO-TT vaccine must be stored at temperatures between +2°C to +8°C.
  • DO NOT FREEZE.
  • Expiry date 3 years.

PRESENTATION
Bio-TT®
Box : 10 ampoules @ 0.5 mL (1 dose)